Many pharmacologically important natural products are assembled by modular type I polyketide synthases (PKS), which typically act in a unidirectional fashion. The synthases producing the unusual nitrosubstituted polyketides neoaureothin (nor, also called spectinabilin) and aureothin (aur) are exceptional, as they employ individual modules iteratively. Here, we investigate the plasticity of the nor PKS and the factors governing the number of elongations catalyzed by the noncanonical module. Surprisingly, we observe that the nor PKS can mediate an additional chain elongation to yield the higher homolog homoneoaureothin. Furthermore, we design several truncated variants of the nor PKS to use them in the context of artificial assembly lines for aureothin and homoaureothin. The resulting polypropionate derivatives provide valuable insights into chain length control and reveal structure-activity relationships relating to the size of the polypropionate backbones. Overall, we show that iterative modules are remarkably adaptable while downstream modules are gatekeepers that select for correct polyketide chain length.
INTRODUCTION
Bacterial modular type I polyketide synthases (PKS) are giant multifunctional enzymes that are responsible for the biosynthesis of many pharmacologically relevant polyketides. These diverse multienzyme systems efficiently synthesize highly complex polyketide metabolites from simple acyl and malonyl units (Fischbach and Walsh, 2006; Hertweck, 2009; Khosla et al., 2009) . In general, each PKS module minimally contains a ketosynthase (KS), catalyzing the Claisen condensation of activated acyl and malonyl units, an acyl transferase (AT) for selecting the extender unit, and an acyl-carrier protein domain (ACP), to which the acyl chain is tethered. After every chain elongation, the b keto group may be optionally processed by ketoreductase, dehydratase (DH), and enoyl reductase (ER) domains.
Finally, a thioesterase (TE) domain typically off loads the fully elongated polyketide chain from the enzyme complex. As a result of the unidirectional assembly, the number and architecture of the modules typically corresponds with the structure of the polyketide backbone. This rule of colinearity has been employed to rationalize the evolution of metabolic diversity, as it is very conceivable that the acquisition or duplication, rearrangement, and deletion of domains and entire modules have changed the program of polyketide assembly (Jenke-Kodama et al., 2006 Nguyen et al., 2008) . This biosynthetic concept has set the basis for rationally engineering polyketide metabolites (Poust et al., 2014; Weissman and Leadlay, 2005; Wong and Khosla, 2012) and to predict polyketide structures from PKS gene sequences (Challis, 2008; Helfrich et al., 2014; Winter et al., 2011) .
Nonetheless, several modular PKSs act in a noncolinear fashion. Congeners of the main polyketide products have been isolated that point to the accidental skipping of individual domains or the iterative use of modules (Hardt et al., 2001; Wilkinson et al., 2000) . Apart from such error-prone PKSs that lack fidelity, a growing number of modular PKSs have been reported that breach the rule of colinearity; in such noncanonical assembly lines, the iterative use of individual PKS components has been shown to be a programmed event . First indications for an iterative use of modules in a modular assembly line were gained by analysis of the biosynthetic codes for stigmatellin (Gaitatzis et al., 2002) , borrelidin (Olano et al., 2003 (Olano et al., , 2004 , and aureothin Hertweck, 2003, 2005) . Noncolinear type I PKSs were also identified in the biosynthetic pathways leading to lankacidin (Arakawa et al., 2005) , neocarzilin (Otsuka et al., 2004) , and neoaureothin (Traitcheva et al., 2007) , and more recently, cryptic PKS programming was revealed for the etnangien (Menche et al., 2008) and crocacin (Mü ller et al., 2014) PKSs. The possibility of duplicated gene products, which could theoretically account for additional chain elongations, was ruled out by PKS gene fusions that yielded the correct architectures of borrelidin (Olano et al., 2003) , aureothin , and lankacidin (Tatsuno et al., 2007) . On the other hand, when taken out of its natural context, a module of the colinear picromycin PKS proved to be capable of catalyzing two rounds of elongations (Beck et al., 2003) . Furthermore, a ratchet mechanism seems to prevent the upstream movement of intermediates in colinear assembly lines such as the erythromycin PKS (Kapur et al., 2012 ). Yet, the cause for iteration in modular, noncolinear PKSs is only little understood and poses one of the major riddles in polyketide biosynthesis.
The aureothin/neoaureothin family of polypropionates represents a versatile model system to address this issue. Neoaureothin (also known as spectinabilin, 1) and aureothin (2) are unusual nitroaryl-substituted pyrone metabolites from Streptomyces orinoci and Streptomyces thioluteus, respectively ( Figure 1) ; they share the same structural features and building blocks Mü ller et al., 2006a) and differ solely in the size of the central polyene stretch (Busch and Hertweck, 2009 ). Through analysis of the neoaureothin (nor) and aureothin (aur) biosynthesis gene clusters, gene fusions, mutagenesis, and cross-complementation, we have found that the diene moiety of 2 is generated by an iteratively acting module (AurA) (He and Hertweck, 2003) , whereas one iterative module and two noniterative modules assemble the tetraene backbone of 1 (Figure 2A ) (Traitcheva et al., 2007) . In silico analyses of the aur and nor PKSs indicated that the aur PKS has evolved from the nor PKS by gene deletion. This model is supported by the successful cross-complementation experiments of the first modules, which proved to be functionally equivalent (Traitcheva et al., 2007) . Mutational studies revealed the mechanism of intermediate retrotransfer from one polypeptide strand of the PKS homodimer onto the other (Busch et al., 2012) . Module iteration was also observed in an artificial luteoreticulin (3) (lut) PKS obtained through redesign of the aureothin PKS (Sugimoto et al., 2014) . Notably, the lowest homolog, orinocin (4), is not generated by an even smaller PKS but results from a photoinduced polyene splicing of 1 (Mü ller et al., 2006b) .
Whereas in the intact aur, lut, and nor PKS systems, the first module catalyzes two rounds of elongations, the freestanding module is even capable of triple and quadruple iterations (Figure 2B) (Busch et al., 2013) . This finding implies that multiple factors control whether a module iterates or not, and it was proposed that kinetic factors and the substrate specificity of the downstream modules could play key roles in noncolinear assembly lines (Busch et al., 2013) .
Here, we report the successful heterologous reconstitution of the noncolinear neoaureothin PKS and several rationally designed assembly lines, which not only provided new insights into the regulation of neoaureothin biosynthesis but also yielded two missing members of the (neo)aureothin family. Beyond providing structure-activity relationships regarding the size of the polypropionate backbone, these data reveal a remarkable adaptability of iterative modules and a rather rigid gatekeeping by downstream modules to control polyketide assembly.
RESULTS AND DISCUSSION
Reconstitution and Heterologous Expression of the nor PKS To gain a deeper insight into the noncolinear PKS systems and their evolution, we aimed at the heterologous expression and targeted manipulation of the nor biosynthetic gene cluster. Fragments of the neoaureothin biosynthesis gene cluster were located on two cosmids, pSO1A9 and 24D5, in a library of Streptomyces orinoci total DNA fragments (Traitcheva et al., 2007) ( Figure 3A ). Since recombination-based fusion experiments led to unwanted results such as rearrangements, a two-plasmid system was employed for the heterologous expression of the gene cluster. A large fragment covering most nor genes (norD-B; from pSO1A9) was cloned into E. coli-Streptomyces shuttle vector pKJ01 (Jakobi and Hertweck, 2004) , and the gene cassette norBCI (from pSO24D5) was cloned into the pKJ55 vector (Ishida et al., 2007) downstream of the constitutive ermE* promoter. The resulting clones, pNT40 and pNT42, were introduced into the expression host (S. lividans ZX1). However, no neoaureothin production was detected by high-performance liquid chromatography (HPLC)-mass spectrometry (MS) analysis of the culture broth.
Transcription and metabolic analyses suggested that genes under the control of the constitutive ermE* promoter were expressed, whereas genes under the control of the natural regulatory system were downregulated. This finding is not surprising, as the putative regulator of the nor gene cluster, NorD, is similar to the transcriptional repressor ArsR (Bairoch, 1993) . Thus, to induce gene expression, we performed an in-frame deletion of norD by PCR targeting. The resulting plasmid, pNT87, was introduced into S. lividans ZX1::pNT42. Unexpectedly, the mutant strain did not produce any neoaureothin either, which pointed to a more complex regulation.
By inspection of the flanking regions of the nor gene locus, we found two additional genes, norR and norZ, which might be involved in regulation and resistance, upstream of the gene cluster. NorR is related to transcriptional activators of the AfsR family, whereas norZ likely encodes a transporter of the major facilitator superfamily. In order to investigate whether these two genes were involved in the regulation of the neoaureothin pathway, they were excised from cosmid pSO20D4 and cloned into pBU12, an SCP2*-based self-replicating vector derived from pRM5 (McDaniel et al., 1993) . The resulting plasmid (pBU145) was introduced into S. lividans::pNT42/pNT40. HPLC-MS analysis of the metabolic profile of the mutant showed that neoaureothin was produced, albeit only in trace amounts.
To improve neoaureothin production, we sought to upregulate gene expression using a genuine regulatory system and turned to the working aur gene expression constructs. The aur gene cluster harbors a putative transcriptional regulator gene (aurD) ( Figure 3A ) (He and Hertweck, 2003) . Unlike NorD, AurD shows sequence similarity to transcriptional activators of the AfsR family (Horinouchi et al., 1990) . Given the similarities of the aur and nor gene cluster sequences, we postulated that coexpression of aurD could activate the nor gene cluster in the absence of norD. To test this hypothesis, we constructed an aurD expression plasmid. The activator gene was cloned into pBU12 downstream of the actII-ORF4 promoter, and the resulting plasmid (pYU1) was introduced into S. lividans ZX1 together with pNT42 and pNT87. The HPLC profile of the resulting strain (S. lividans ZX1::pNT42/pNT87/pYU1) showed neoaureothin production at substantially increased titers (15 mg l À1 ) (Figure 4A) . Although the amount of neoaureothin produced by heterologous expression is lower than in the wild-type producer S. orinoci (90 mg l À1 ), the production rate was dramatically improved in comparison with any of the other mutants. Our findings are also intriguing from an evolutionary point of view. Analysis of the spectinabilin biosynthesis gene cluster from S. spectabilis (Choi et al., 2010 ) revealed a high sequence identity to both the aureothin and neoaureothin PKS genes. Moreover, the regulator gene was highly homologous to aurD, which may indicate that the spectinabilin biosynthesis gene cluster could represent an evolutionary link between the nor and aur gene clusters. A plausible scenario would be the replacement of norD with an aurD-like gene encoding a transcriptional activator. Thereafter, the PKS genes would be rearranged to yield a shorter type I PKS.
Discovery of a Neoaureothin Homolog Produced by the nor PKS
The successful heterologous production of neoaureothin not only set the stage for pathway engineering experiments. When inspecting the metabolic profile of the heterologous producer strain, we unexpectedly noted that small amounts (0.025 mg l
À1
) of a novel metabolite (5) are formed. The high-resolution MS spectrum revealed that 5 has the molecular formula C 31 H 36 NO 6 . Comparison of the 1 H nuclear magnetic resonance (NMR) spectra of 1 and 5 showed one additional couple of olefinic and methyl . The E (C11-C18) and Z (C9) configurations were inferred from nuclear Overhauser effect spectroscopy (NOESY) data. Its absolute configuration was deduced from comparisons of CD spectra of 5, 1, and 2, which all show similar curve shapes (Supplemental Information). Reinvestigation of the wild-type metabolome by HPLC-MS revealed that traces of 5 are also formed in the genuine PKS system, but this compound was previously overlooked because of the metabolic background of S. orinoci. The discovery of 5 is intriguing, as the structure of the pentaene implies an additional iterative use of a PKS module. In principle, it would be conceivable that the additional chain elongation was mediated by one of the downstream modules (module 2 or 3), which have a similar architecture to the iterative module 1. However, using the NorA homolog AurA as a standalone PKS component of the aureothin PKS, we have recently demonstrated that iteration of the first module is not restricted to two elongations; it can also generate longer chains, which result from three or even four elongations (Busch et al., 2013) . NorA is functionally equivalent to AurA, and we have demonstrated by crosscomplementation that NorA can even replace AurA to yield a functional aur PKS. Thus, it is more likely that NorA catalyzes three rounds of chain elongations, and the intermediate is then elongated by each module 2 and 3 in a colinear fashion to yield the pentaene.
Morphing of the nor PKS into Artificial aur PKS-like Assembly Lines
The nor and aur PKS exhibit similar architectures, and the multiple use of the first module raised the question whether it could be possible to generate aur PKS-like systems from the nor PKS that produce either neoaureothin or aureothin. In fact, bioinformatics analyses suggest that the aur and nor genes have an evolutionary relationship. According to the phylogeny, the most parsimonious scenario is that the aureothin biosynthesis gene cluster evolved from the nor gene locus through loss of norA 0 (Traitcheva et al., 2007) . To test this hypothesis and to emulate this evolutionary scenario, we constructed several truncated neoaureothin assembly lines. First, we sought to generate an aur PKS from the nor PKS. To formally achieve this goal, modules 2 and 3 were excised. However, as it was deemed necessary to maintain the appropriate ACP-KS docking domain regions (Weissman, 2006) and the substrate specificity of KS2, the boundaries between the KS domains and KS-AT linkers in modules 2 and 4 were chosen as fusion sites ( Figure 5 ). The corresponding gene region was substituted with a spectinomycin resistance cassette (addA) flanked by HpaI restriction sites by PCR targeting. After successful recombination of the targeted gene region in Escherichia coli, the cassette was removed by digestion with HpaI and subsequently religated to generate the seamless fusion ( Figure 3C ). The resulting construct encoding the aur* PKS (pYU48 together with pNT42 and pYU1) was introduced into S. lividans for heterologous expression. The culture extracts of various cultures of verified transformants were monitored by HPLC-MS, but aureothin production could not be detected.
There are various possible reasons for the inability of the aur* PKS mutant to produce aureothin. The engineered PKS could be nonfunctional because of misfolding of the chimeric polypeptide, and the interaction between the KS and ACP domains could be suboptimal, which might hamper polyketide assembly (Hans et al., 2003) . Since related constructs were functional, a more plausible explanation would involve the function and substrate specificities of the PKS modules. The first four nor PKS modules can biosynthesize hexa-and heptaketides, which are further extended by modules 5 and 6 to yield tetraene 1 and pentaene 5. In the aur* PKS, module 1 and hybrid module 2/4 would primarily produce a tetraketide, which is likely not accepted as a substrate of the downstream KS5 domain.
Next, we sought to generate an aur-like PKS to test whether or not the iterating first module could compensate for two missing downstream modules (aur # PKS). Therefore, we deleted norA 0 and fused the KS2 docking domain to KS4 ( Figure 5 ). In this construct, the overall PKS architecture would be the same as in the aur and aur* PKS, but the formation of neoaureothin would be expected because of the different KS specificity. To construct the aur # fusion PKS, the same method as for the aur* PKS construction was employed, except for the used restriction site (AvrII). The gene region encoding from KS2 to KS4 except for the N-terminal linker of module 2 was substituted with an extended spectinomycin resistance cassette flanked by AvrII restriction sites in E. coli. After recombination, the cassette was removed by AvrII digestion and religation to yield the aur # PKS gene ( Figure 5 ). The recombinant expression plasmid (pYU69) was then introduced into S. lividans together with pNT42 and pYU1. By HPLC analysis of the aur # PKS mutant culture, neither neoaureothin nor its homologs could be detected.
We demonstrated earlier that AurA is capable of producing polyketides with up to four propionate units, at least as a freestanding enzyme (Busch et al., 2013) . The in vivo experiments above indicated that the functionally equivalent first module of the nor PKS (NorA) can produce intermediates with diene and even triene backbones. In principle, the pentaketide should be accepted by KS4, as shown in the heterologously reconstituted full-length nor PKS. Yet, apparently, the tetraene is not formed in the context of the PKS complex or the titers are too low to allow for the detection of the final product, and the shorter polyketide Rational Design of a Missing Member of the Aureothin Family The two constructs described above indicate that the lack of two modules cannot be compensated by the engineered assembly lines. Thus, we aimed at generating a truncated assembly line lacking only a single module to further evaluate the plasticity of the nor PKS. Specifically, we sought to design a truncated assembly line that would yield a nonnatural congener with a triene backbone, homoaureothin (6), the missing member of the aureothin family of polypropionates.
For the construction of a homoaureothin-forming (har) PKS, the gene region coding for regions between the KS of module 2 and the KS-AT linker in module 3 were deleted from the nor PKS gene by PCR targeting. The corresponding gene region was substituted with a spectinomycin resistance cassette franked by HpaI restriction sites. After successful replacement of the targeted gene region in E. coli, the cassette was removed by digestion with HpaI and religated to generate a seamless fusion. The resulting plasmid (pYU50) ( Figure S3 ) was introduced into the heterologous host S. lividans ZX1 harboring pNT42 and pYU1. By HPLC-MS monitoring of the fermentation broth of the recombinant strain, we observed the production of a novel compound (6, 0.33 mg l À1 ), and high-resolution MS (HRMS) revealed the expected molecular formula of C 25 H 27 NO 6 for homoaureothin (Figure 4) .
Compound 6 was isolated from the mycelium and culture broth of a 20 l fermentation and purified by open column chromatography, followed by preparative HPLC.
1 H NMR, 13 C NMR, 1 H-1 H correlation spectroscopy (COSY), and HSQC spectral analyses corroborated the presence of a p-nitrobenzoate moiety, furan ring, and pyrone ring and confirmed that 6 lacks one double bond compared with neoaureothin. HMBC correlations of methyl protons H2a (d 3.91), H3a (d 1.82), H5a (d 1.99), H11a (d 2.01), H13a (d 2.03), hydroxyl methine proton H7 (d 5.09), hydroxyl methylene protons H9a (d 4.69, 4.81) , and the olefinic proton H14 (d 6.39) to adjacent carbons fully support the proposed structure of 6 (Supplemental Information). The E (C11-C14) and Z (C9) configurations were deduced from NOESY data, and comparison of CD spectra showed that the absolute configuration at C7 is the same as in the congeners. Thus, we have successfully morphed the nor assembly line into a PKS that produces homoaureothin.
Furthermore, by thorough liquid chromatography (LC)-HRMS examination of the metabolic profile of the homoaureothin-producing mutant and comparison with an authentic reference, we also detected trace amounts of neoaureothin ( Figure 4A ). The formation of the tetraene-bearing product can be explained only by an additional module iteration to compensate for the lack of the third module. This finding also supports the model of homoneoaureothin formation involving an additional iteration.
Iteration Versus Gatekeeping
The metabolic engineering of the neoaureothin assembly line and the isolation of new aureothin/neoaureothin members (5 and 6) teach us a lesson on freedom and constraint in noncolinear assembly lines. We have shown that the KS domains in nor PKS modules can accept and process polyketide intermediates that are either longer or shorter than the genuine substrate. Although relaxed substrate specificities of KS domains have been previously observed in colinear systems (Khosla et al., 1999) , it is an important finding for understanding polyketide processing in noncolinear systems. Considering the ability of the iterative nor or aur PKS modules to catalyze two to four elongations, the downstream modules apparently accept intermediates only within a particular size range. Nonetheless, the gatekeeping does not seem to be affected by different sizes of polyketide starter units in the native aur PKS (Ziehl et al., 2005; Werneburg et al., 2010) .
Although dramatically reduced or even fully abolished polyketide productions may result from suboptimal fusion sites in modular PKS (Kellenberger et al., 2008; McDaniel et al., 1999) , we may exclude this possibility, because the constructs were carefully checked and the same sites were used in the functional har PKS and other functional constructs such as the artificial lut PKSs (Sugimoto et al., 2014) . Beyond structural restrictions of KS and intermediates, it is also conceivable that gatekeeping involves both structural and kinetic factors. In a noncolinear system such as the nor and aur PKSs, there is competition between the speed of retrotransfer to the upstream KS and chain propagation onto the downstream module as well as loading of the KS1 domain with the starter unit. Obviously, the number of elongations is influenced by the biosynthetic context of the specific iterative module. NorA has the freedom to compensate for one (but not two) lacking modules as in the har PKS, and the number of iterations and chain propagations are restricted by the downstream modules, as in the aur* and aur # PKS. Thus, we can deduce that besides the size control of iterative modules, there is a gatekeeping function of the downstream KS to select for the correct substrates.
Impact of Polypropionate Chain Length on Antimicrobial and Antiproliferative Activities
Having the diene, triene, tetraene, and pentaene congeners at hand for the first time, we examined the impact of the size of the polyketide backbone on bioactivities. Using whole-cell assays we analyzed the antimicrobial, cytotoxic, and antiproliferative activities of the pyrones. Moderate antibacterial activities were observed for 2 (Bacillus subtilis) and 6 (Staphylococcus aureus, methicillin-resistant S. aureus [MRSA]) ( Figure 6 ). However, in general, the pyrones exhibit a remarkable selectivity with respect to antifungal activities. Among the compounds and strains tested, a clear trend is visible. Whereas tetraene and pentaene are only moderately active against the representative test strains (Candida albicans, Penicillium notatum, and Sporobolomyces salmonicolor), the triene is substantially more active. The shortest congener, aureothin (2), shows strongest activities against fungi and yeasts in the agar diffusion assay, which is clearly superior to the reference compound amphotericin ( Figure 6A) . Surprisingly, the situation is reversed with respect to the antiproliferative and cytotoxicity assays using K-562 (myelogenous leukemia) and HUVEC (human umbilical vein endothelial cell) cell lines. It is remarkable that the longest polypropionate, homoneoaureothin (5), exhibits the most pronounced antiproliferative and cytostatic activities of the four pyrones ( Figure 6B) . Overall, the pyrones show an unusually flat dose-response curve. These results illustrate that the size of the polypropionate backbone has a clear impact on the biological activities of the pyrone natural products. It would be necessary to consider these findings when designing either antifungal or antiproliferative agents that are inspired by (neo)aureothin-type compounds.
SIGNIFICANCE
Modular PKSs play a major role in the production of pharmaceutically relevant natural products. Understanding the function of the typically unidirectional assembly lines enables the rational design of novel synthases that lead to structural analogs that are difficult to synthesize. The unconventional PKSs of the antifungal and antiproliferative pyrones aureothin and neoaureothin constitute a remarkable model to study factors controlling noncolinear polyketide assembly and evolutionary processes that lead to structural diversity. To redesign the neoaureothin synthase, we reconstituted the entire pathway in a heterologous host. Deletion of a repressor gene and coexpression of an activator gene from the related aureothin pathway not only led to dramatically increased production titers but also provided insight into a plausible evolutionary relationship of the gene clusters. Refactoring the nor PKS into shorter modular PKS systems, we rationally constructed a nonnatural polyketide assembly line to produce a missing member of the neoaureothin/aureothin family. Valuable insight into the plasticity of the iterative modules was gained: an iterative module may compensate for the loss of a module, albeit accompanied by a drop down of productivity. While there is a degree of flexibility in the system that allows for one additional elongation, it appears that downstream modules are gatekeepers that select for the correct size of the polyketide chain. The aur/nor PKSs are fine-tuned multienzyme systems that likely have been selected for the biological activities of the products. Access to four polypropionate homologs for the first time allowed analysis of the structure-activity relationship with respect to the size of the polyketide backbone. Remarkably, the longest congener exhibits enhanced cytostatic effects, whereas antifungal activity increases dramatically with shorter chain lengths. Thus, the results from our pathway engineering approaches may be useful not only for the field of synthetic biology or combinatorial biosynthesis but also from a pharmacological point of view.
EXPERIMENTAL PROCEDURES
Strains and Media E. coli strain TOP10 (Invitrogen) and XL10-Gold (Stratagene) served for routine subcloning. E. coli HB101/pRK2013 and E. coli BW25113/pIJ790 were employed for triparental conjugation (Ditta et al., 1980) and for PCR targeting procedures (Gust et al., 2003) , respectively. E. coli strains were cultured in Luria-Bertani medium supplemented with ampicillin (100 mg ml À1 , Carl Roth), apramycin (50 mg ml À1 , Sigma-Aldrich), kanamycin (25 mg ml À1 , Sigma), chloramphenicol (25 mg ml À1 , Roth), or spectinomycin (100 mg ml À1 , Sigma-Aldrich) for plasmid selection. S. lividans ZX1 (Zhou et al., 1988) , kindly provided by Prof. X. Zhou, was used as the host strain for heterologous expression experiments. For metabolite production, Streptomyces mutant strains were grown with orbital shaking at 28 C in R5 medium for 3 days. This seed culture (2 l) was used to inoculate 20 l of the fermentation media, in modified R5 medium (1 g of casamino acids and without saccharose) in a stainless steel fermenter. After 3 to 4 days, fermentation was stopped. For sporulation, Streptomyces strains were grown on 2CM (complete medium) or MS (mannitol soya flour) agar plates. Conjugation was performed on MS agar supplemented with MgCl 2 (10 mM) and overlaid next day with nalidixic acid (20 mg ml À1 , Carl Roth)
together with appropriate antibiotics. For protoplast transformation, S. lividans strains were grown on YEME (yeast extract and malt extract) or R5 medium and on R5 agar. Apramycin (30 mg ml À1 ), spectinomycin (400 mg ml À1 ), and thiostrepton (5 mg ml À1 ) were used for plasmid selection in Streptomyces strains.
Plasmid and General DNA Procedures DNA isolation, plasmid preparation, restriction digests, PCR, gel electrophoresis, ligation reactions, and transformation were performed according to standard methods for E. coli (Sambrook et al., 1989 ) and for Streptomyces (Kieser et al., 2000) . Restriction enzyme-digested and PCR-amplified DNA fragments were purified from agarose gel by the GFX PCR DNA and Gel Band Purification Kit (GE Healthcare) or Invisorb Spin DNA Extraction Kit (Invitek). E. coli-Streptomyces shuttle vectors pSET152 (Bierman et al., 1992) , pKJ01 (Jakobi and Hertweck, 2004) , and pKJ55 (Ishida et al., 2007) were used for expression in Streptomyces strains.
Reconstitution of the nor PKS Design of Expression Plasmids pNT40, pNT42, and pNT 87 About 35 kb SspI insert of cosmid 1A9, which contains the cos site, was recovered and ligated into the SwaI site of the E. coli-Streptomyces shuttle vector pKJ01, a pRM5 derivative, to give a plasmid pNT40. A 16 kb AfeI fragment from cosmid 24D5, containing norB, C, and I was cloned into the EcoRV site of the pKJ55 vector, a derivative of integrative E. coli-Streptomyces shuttle vector pSET152, equipped with an ermE* promoter, yielding pNT42. Deletion of norD in pNT40 was achieved by PCR targeting. The spectinomycin resistance cassette flanked by FRT sites was amplified by PCR using two primers norDL (5 0 -TGA TTG GCG AAC TAC GAA TGG CTT CGT ACA ATG GGG GTG ATT CCG GGG ATC CGT CGACC-3 0 ) and norDR (5 0 -CGC TCA CCT TTG AAG TCC CAT GGT ACT CCT GCG CGA TCA TGT AGG CTG GAC TGC TTC-3 0 ).
The replacement of norD with the extended cassette was accomplished in E. coli BW25113/pIJ790 containing pNT40 by l RED-mediated recombination. Thereafter, the cassette was removed by the expression of FLP recombinase. The resulting plasmid was named pNT87. Construction of aurD and norR/norZ Expression Plasmid A 5.5 kb XbaI-PmlI fragment from pSO20D4 was inserted into XbaI-SwaI digested pBU12 to give a plasmid pBU145. Plasmid pBU12 was generated by ligation of the 1.4 kb HindIII-EcoRI fragments from pHGF7505 and a blunted 1.3 kb XbaI fragment from pIJ778 into the 11.8 kb HindIII-EcoRI and EcoRV sites from pRM5, respectively. The active regulator gene, aurD, was amplified as a 1.0 kb PacI-EcoRI fragment with two primers aurD_PacI_fw (5 0 -TTA ATT AAA TTC GCG AGA GAG GCG TAT-3 0 ) and aurD_EcoRI_rv (5 0 -GAA TTC AAC GGC AAG ATC CAG AAG G-3 0 ) from pHJ48 (He and Hertweck, 2003) . The PCR product was cloned into PacI-EcoRI-digested pBU12 to give a plasmid pYU1.
Construction of aur* PKS Mutant
Cosmid pNT87 was reduced in size by means of PCR targeting. Two long primers, pNT87_shrink_fw (5 0 -ACC TTT ATG GAG GTG GGG CCG TCC GGG ACG CTC ACC GCC ATG CAG TGG GCT TAC ATG GCG-3 0 ) and pNT87_schrink_rv (5 0 -GGG CGC CAT GCG TGG TCA CCA GGT GCC GGA CCA CCA GAC GAC GCA GGA AAG AAC ATG TGA-3 0 ) were designed. A 2.7 kb PCR product was amplified from pCR2.1 TOPO as a template and introduced into E. coli BW25113/pIJ790 harboring pNT87 and resulted in construct pYU31. In order to delete the gene region encoding between AT2 and KS4 domains, two long primers KS2_fw_HpaI (5 0 -AAC GCC CAT GTC ATC CTG GAA CAG GCC GAG CAG CCC CCG GTT AAC GGA ACT TCG AAG TTC CCG CC-3 0 ) and KS4_rv_HpaI (5 0 -CGG GAT GTC CGC GCC CTC CGG CCC GTC CGT CAT CTC CCC GTT AAC GGA ATA GGA ACT TCA TGA GC-3 0 ) were designed and used to amplify a spectinomycin resistance cassette flanked by HpaI restriction sites from pIJ778 as a template. Boundaries of KS2-AT2 linker and KS4-AT4 linker were chosen as fusion sites (Figure S2 available online) . The PCR product was used to transform E. coli BW25113/pIJ790 harboring pYU31. The replacement of the target gene region with the spectinomycin resistance cassette was achieved by l REDmediated recombination. A 2.3 kb StuI-EcoRI fragment from resulting plasmid pYU34 was introduced into E. coli BW25113/pIJ790 containing pNT87 and resulted in construct pYU47. pYU47 was digested with HpaI and religated to remove the resistance cassette. Finally, the expression plasmid pYU48 for aur* PKS was obtained.
Construction of the aur # PKS Mutant
The aur # PKS mutant was constructed using a recombination strategy in analogy to the construction of the aur* PKS mutant. In order to delete gene region encoding AurA 0 except for the N-terminal linker, two long primers, KS2_fw_HpaI_3 (5 0 -GTG CAG ACC CGT GAA CGC CTG CGG ACC GCC CAG GCG GCG CCT AGG GGA ACT TCG AAG TTC CCG CC-3 0 ) and KS4_rv_HpaI_3 (5 0 -GGG GAA GCG GCA GCC CAT GGC CAC CAC CGC CAC CGG TTC CCT AGG GGA ATA GGA ACT TCA TGA GC-3 0 ) were designed to amplify a spectinomycin resistance cassette flanked by AvrII restriction sites. Boundaries of KS2 and KS4 were chosen as fusion sites ( Figure S2 ). The extended PCR fragment was introduced into E. coli BW25113/pIJ790 harboring pYU50 (see the section on construction of har PKS) to replace the target gene region for a spectinomycin resistance cassette. A resulting plasmid pYU67 was digested with AvrII and religated to remove the resistance cassette, yielding the expression plasmid pYU69 for the aur # PKS.
Construction of the har PKS Mutant
In order to delete the genes encoding between the AT2 and KS3 domains, two primers KS2_fw_HpaI (5 0 -AAC GCC CAT GTC ATC CTG GAA CAG GCC GAG CAG CCC CCG GTT AAC GGA ACT TCG AAG TTC CCG CC-3 0 ) and KS4_rv_HpaI (5 0 -CGG GAT GTC CGC GCC CTC CGG CCC GTC CGT CAT CTC CCC GTT AAC GGA ATA GGA ACT TCA TGA GC-3 0 ) were designed and a spectinomycin resistance cassette flanked by HpaI restriction sites was amplified from pIJ778 as a template. Boundaries of KS2-AT2 linker and KS3-AT3 linker were chosen as fusion sites ( Figure S2) . A 1.4 kb fragment was used to transform E. coli BW25113/pIJ790 harboring pYU31. Replacement of the target gene region with the resistance cassette was achieved by l RED-mediated recombination. An 8.7 kb EcoRI-EcoRV fragment from the resulting plasmid (pYU35) was introduced into E. coli BW25113/pIJ790 containing pNT87, which gave construct pYU49 after recombination. To remove the resistance cassette, pYU49 was restricted by HpaI and religated. Finally, an expression plasmid pYU50 was obtained.
General Analytical Procedures NMR spectra were measured on either a Bruker Avance DRX 500 MHz or 600 MHz spectrometer (600 MHz with a cryoprobe) in CDCl 3 at 300 K. Spectra were referenced to the residual solvent peak. UV spectra were obtained on a Shimadzu UV-1800 spectrophotometer. Optical rotation was obtained by JASCO P-1020 polarimeter. CD spectra were measured on a JASCO J-815 CD spectrometer. High-resolution electrospray ionization mass spectrometry and LC-HRMS measurements were carried out on a Thermo Fisher Scientific Exactive Orbitrap with an electrospray ion source using a Betasil 100-3 C 18 column (150 3 2.1 mm) and an elution gradient (solvent A, H 2 O + 0.1% HCOOH; solvent B, acetonitrile; gradient, 5% B for 1 min, 5% to 98% B in 15 min, 98% B for 3 min; flow rate, 0.2 ml min 1 ). LC-MS measurements for the LC chromatogram were carried out on a Hewlett Packard 1100 Series using an OD-5-100/ 253-Reversed-Phase C 18 column from SMT and an elution gradient (solvent A, H 2 O + 0.1% HCOOH; solvent B, acetonitrile; gradient, 0.5% to 99.5% B in 37 min, 99.5% B for 1 min, 99.5% to 0.5% in 2 min; flow rate, 0.8 ml min À1 ).
Antimicrobial Assays
Sterile filter paper disks were impregnated with 50 mg of the samples using methanol as the carrier solvent. 
Isolation of Homoneoaureothin, 5
Mycelium of Streptomyces lividans ZX1::pNT42, pNT87, pYU01 from a 20 l culture was extracted with methanol (2 l). After the solvent was removed under reduced pressure, the extract was subjected to silica gel column chromatography (5 3 23 cm, silica gel 60, 0.040-0.063 mm) using a dichloromethane/ methanol gradient. Two fractions that contained 1 and 5 were subjected to preparative RP-HPLC (Eurosphere C18, 20 3 250 mm, flow rate 12 ml min À1 ) using a gradient of solvents A (40% acetonitrile) and B (100% acetonitrile), 0% B in 10 min to 100% B in 30 min and kept for 15 min, to yield 1 (111.7 and 110.2 mg) and a fraction containing 5. This fraction was subjected to preparative RP-HPLC (Phenomenex fusion RP, 20 3 250 mm, flow rate 12 ml min À1 ) using a gradient of solvents A (60% acetonitrile) and B (100% acetonitrile), 0% B in 10 min to 100% B in 20 min and kept for 15 min, to obtain crude homoneoaureothin. Further purification by semipreparative RP-HPLC (Phenomenex phenylhexyl, 10 3 250 mm, flow rate 6 ml min À1 ) yielded pure 5 (0.5 mg). The supernatant from 20 l of Streptomyces lividans ZX1::pNT42, pNT87, pYU01 was extracted with ethyl acetate (40 l). After the solvent was removed under reduced pressure, the residue was subjected to silica gel column chromatography (5 3 10 cm, Silica gel 60, 0.040-0.063 mm) using a dichloromethane/methanol gradient. The neoaureothin-containing fractions were combined and then subjected to silica gel column chromatography (3 3 8 cm, LiChroprep Si60, 0.015-0.025 mm) using a chloroform/methanol gradient. Fractions enriched with the target compound were subjected to preparative RP-HPLC (Phenomenex fusion RP, 20 3 250 mm, flow rate 12 ml min À1 ) using a gradient of solvents A (60% acetonitrile) and B (100% acetonitrile), 0% B in 10 min to 100% B in 20 min and kept for 15 min, to yield 1 (130.1 mg).
Isolation of Homoaureothin, 6
Mycelium of Streptomyces lividans ZX1::pNT42/pYU50/pYU01 from a 20 l culture was extracted with methanol (40 l). After the solvent was removed under reduced pressure, the extract was subjected to silica gel column chromatography (5 3 23 cm, silica gel 60, 0.040-0.063 mm) using a dichloromethane/ methanol gradient. A homoaureothin-containing fraction was further subjected to preparative RP-HPLC (Eurosphere C18, 20 3 250 mm, flow rate 12 ml min À1 ) using a gradient of solvents A (40% acetonitrile) and B (100% acetonitrile), 0% B in 10 min to 100% B in 30 min and kept for 15 min, to yield crude homoaureothin and trace amounts of neoaureothin (1, <0.1 mg). Crude homoaureothin was subjected to preparative RP-HPLC (Phenomenex fusion RP, 20 3 250 mm, flow rate 12 ml min À1 ) using a gradient system of solvents A (60% acetonitrile) and B (100% acetonitrile), 0% B in 10 min to 100% B in 20 min and kept for 15 min, to yield 6 (6.6 mg). Table S1 .
ACCESSION NUMBERS
The GenBank accession number for the norZ gene reported in this paper is KP719210. The GenBank accession number for the norR gene reported in this paper is KP719211.
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